Assets Held-For-Sale and Discontinued Operations (Tables)

12 Months Ended

Feb. 02, 2019

Assets Held For Sale And Discontinued Operations [Abstract]

Schedule of major classes of assets and liabilities

The following table provides a reconciliation of the carrying amounts of major classes of assets and liabilities which are included in assets and liabilities held for sale in the accompanying consolidated balance sheet for each of the periods presented:

	Specialty Pharmacy				Retail Pharmacy				Headquarters Building				Total Assets Held for Sale
	February 2,		February 3,		February 2,		February 3,		February 2,		February 3,		February 2,		February 3,
	2019		2018		2019		2018		2019		2018		2019		2018
(in thousands)
Current assets:
Receivables, less allowance for doubtful    accounts	$	—	$	15,983	$	—	$	—	$	—	$	—	$	—	$	15,983
Inventories		—		3,756		—		15,344		—		—		—		19,100
Other non-trade receivables		—		152		—		—		—		—		—		152
Prepaid expenses and other current assets		—		12		—		—		—		—		—		12
Total current assets held for sale	$	—	$	19,903	$	—	$	15,344	$	—	$	—	$	—	$	35,247
Property and equipment, less accumulated    depreciation and amortization		—		1,036		—		—		4,839		4,927		4,839		5,963
Goodwill		—		30,609		—		—		—		—		—		30,609
Intangible assets, net		—		9,533		—		20,541		—		—		—		30,074
Other noncurrent assets, net		—		539		—		—		—		—		—		539
Total noncurrent assets held for sale	$	—	$	41,717	$	—	$	20,541	$	4,839	$	4,927	$	4,839	$	67,185
Current liabilities:
Accounts payable		—		22,045		—		—		—		—		—		22,045
Accrued expenses and other		—		4,527		—		—		—		—		—		4,527
Total current liabilities held for sale	$	—	$	26,572	$	—	$	—	$	—	$	—	$	—	$	26,572
Deferred income taxes		—		—		—		—		—		—		—		—
Other noncurrent liabilities		—		48		—		—		—		—		—		48
Total noncurrent liabilities held    For sale	$	—	$	48	$	—	$	—	$	—	$	—	$	—	$	48

Schedule of discontinued operations

The following table summarizes the results of discontinued operations for the years ended February 2, 2019 and February 3, 2018, respectively.

Discontinued Operations – Specialty Pharmacy

(in thousands)	2018			2017
Revenues	$	90,112		$	275,952
Cost of Goods Sold		88,454			264,153
Gross Margin		1,658			11,799
Depreciation and amortization		796			2,630
Impairment expense		—			11,422
Selling, general and administrative expenses		11,952			11,778
Loss from discontinued operations before    income taxes		(11,090	)		(14,031	)
Loss on sale of assets		(446	)		—
Income tax expense		—			(3,113	)
Loss from discontinued operations, net of tax	$	(11,536	)	$	(10,918	)

Discontinued Operations – Retail Pharmacy

(in thousands)	2018			2017
Revenues	$	329,326		$	409,560
Cost of Goods Sold		264,712			314,216
Gross Margin		64,614			95,344
Depreciation and amortization		4,071			7,279
Impairment Expense		—			1,123
Selling, general and administrative expenses		70,537			81,670
Income (Loss) from discontinued operations before    income taxes		(9,994	)		5,272
Gain on sale of assets		145,746			—
Income tax expense		—			—
Income from discontinued operations, net of tax	$	135,752		$	5,272

Total Discontinued Operations

(in thousands)	2018			2017
Revenues	$	419,438		$	685,512
Cost of Goods Sold		353,166			578,369
Gross Margin		66,272			107,143
Depreciation and amortization		4,867			9,909
Impairment Expense		—			12,545
Selling, general and administrative expenses		82,489			93,448
Loss from discontinued operations before    income taxes		(21,084	)		(8,759	)
Gain on sale of assets		145,300			—
Income tax expense		—			(3,113	)
Income (loss) from discontinued operations, net of tax	$	124,216		$	(5,646	)